Hap Trading, LLC Gritstone Bio, Inc. Call Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$1.77 - $4.34 $31,683 - $77,686	-17,900 Reduced 63.48%	10,300 $1,000
Q1 2022 May 12, 2022	SELL	$4.03 - $12.19 $8,866 - $26,818	-2,200 Reduced 7.24%	28,200 $4,000
Q4 2021 Feb 14, 2022	BUY	$8.76 - $13.71 $114,756 - $179,601	13,100 Added 75.72%	30,400 $70,000
Q3 2021 Nov 10, 2021	BUY	$6.41 - $13.54 $110,893 - $234,241	17,300 New	17,300 $38,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.